Literature DB >> 9260689

Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells.

H Isomura1, M Yamada, M Yoshida, H Tanaka, T Kitamura, M Oda, S Nii, Y Seino.   

Abstract

Human herpesvirus 6 (HHV-6) has been reported to be involved in bone marrow failure after bone marrow transplantation (BMT). To elucidate the role of HHV-6 in the marrow failure, we examined the comparative effect of two variants of HHV-6 (HHV-6A and HHV-6B) and human herpesvirus 7 (HHV-7) on in vitro colony formation of hematopoietic progenitor cells in methylcellulose semi-solid media. Progenitor cells prepared from cord blood mononuclear cells (CBMNCs) were infected with one of these viruses at various multiplicity of infection (MOI), and were subjected to methylcellulose colony assay. Formation of both granulocyte/macrophage (CFU-GM) and erythroid (BFU-E) colonies was MOI-dependently suppressed after infection with the Z29 strain of HHV-6B. Although HHV-6A suppressed the formation of BFU-E colonies as efficiently as HHV-6B, the former did not exhibit significant suppressive effect on the formation of CFU-GM colonies at an MOI 1. HHV-7 had no effect on hematopoietic colony formation at all. Based on frequent positivity of viral DNA in single colonies obtained from HHV-6-infected progenitor cells by polymerase chain reaction and in situ hybridization, direct effects of HHV-6 on the hematopoietic progenitor cells are suggested as the cause of the suppression rather than indirect effects via accessory cells of the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260689     DOI: 10.1002/(sici)1096-9071(199708)52:4<406::aid-jmv11>3.0.co;2-e

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  Thymus transplantation.

Authors:  M Louise Markert; Blythe H Devlin; Elizabeth A McCarthy
Journal:  Clin Immunol       Date:  2010-03-16       Impact factor: 3.969

3.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.

Authors:  Armin Rashidi; Maryam Ebadi; Bassil Said; Qing Cao; Ryan Shanley; Julie Curtsinger; Nelli Bejanyan; Erica D Warlick; Jaime S Green; Claudio G Brunstein; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Am J Hematol       Date:  2018-05-14       Impact factor: 10.047

Review 5.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

6.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

7.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 8.  Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients.

Authors:  Duncan A Clark
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

Review 9.  Molecular monitoring of viral infections after hematopoietic stem cell transplantation.

Authors:  Per Ljungman
Journal:  Int J Hematol       Date:  2010-04-23       Impact factor: 2.319

10.  Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

Authors:  Najla El Jurdi; John Rogosheske; Todd DeFor; Nelli Bejanyan; Mukta Arora; Veronika Bachanova; Brian Betts; Fiona He; Shernan Holtan; Murali Janakiram; Samantha Larson; Joseph Maakaron; Armin Rashidi; Erica Warlick; John E Wagner; Jo-Anne H Young; Daniel Weisdorf; Claudio G Brunstein
Journal:  Transplant Cell Ther       Date:  2020-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.